未名醫藥(002581.SZ):第一大股東被司法拍賣的5720.4萬股 由嘉聯私募、易聯技術競得
格隆匯5月27日丨未名醫藥(002581.SZ)公佈,公司第一大股東北京北大未名生物工程集團有限公司持有的公司股份5720.4萬股,佔其所持公司股份總數的74.84%,佔公司總股本的8.67%,於2022年5月25日10時至2022年5月26日10時止(延時除外)在淘寶網司法拍賣網絡平台上進行公開拍賣。經查詢淘寶網司法拍賣網絡平台獲悉,此次拍賣已成交。
公司通過“淘寶網”之“淘寶網—阿里拍賣”平台查詢到的《網絡競價成功確認書》獲悉:經公開競價,用户姓名為深圳嘉聯私募證券投資基金管理有限公司、深圳市易聯技術有限公司,競買代碼:Z5345,以最高競價成功競得公司5720.4萬股股票,拍賣成交價為人民幣約7.79億元,在網絡拍賣中競買成功的用户,必須依照標的物《競買須知》、《競買公吿》要求,按時交付標的物網拍成交餘款、辦理相關手續。標的物最終成交以深圳市福田區人民法院出具拍賣成交裁定為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.